| P2093 | author name string | Alfredo Di Leo | |
| | Angus W Thomson | |
| | Francesca D'Errico | |
| | Antonio Massaro | |
| | Maria Rendina | |
| | Salvatore Fabio Rizzi | |
| | Sonia Carparelli | |
| | Antonino Castellaneta | |
| P2860 | cites work | Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells | Q73112924 |
| | Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients | Q73465317 |
| | Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults | Q79313503 |
| | The ICOS molecule plays a crucial role in the development of mucosal tolerance | Q81512249 |
| | Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C | Q81922494 |
| | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 |
| | ICOS is essential for effective T-helper-cell responses | Q28594859 |
| | Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses | Q31838449 |
| | HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells | Q33782535 |
| | Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry | Q34277755 |
| | CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. | Q34554035 |
| | Mouse and human dendritic cell subtypes | Q34576401 |
| | Dendritic cells, tolerance induction and transplant outcome | Q34740521 |
| | HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance | Q34927885 |
| | Regulatory T cells in transplantation tolerance | Q35092535 |
| | CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection | Q35202450 |
| | Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells | Q36370232 |
| | Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C. | Q36535789 |
| | Tolerogenic dendritic cells and the quest for transplant tolerance | Q36879029 |
| | Dendritic cells, the liver, and transplantation | Q37008790 |
| | Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin | Q37317873 |
| | Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection | Q37446021 |
| | Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance? | Q37687786 |
| | Complexity of dendritic cell subsets and their function in the host immune system | Q37882747 |
| | Regulatory cells and cell signatures in clinical transplantation tolerance | Q37943546 |
| | HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor | Q40705349 |
| | PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. | Q42017650 |
| | Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial | Q42228718 |
| | Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand | Q42767299 |
| | Presence of functional dendritic cells in patients chronically infected with hepatitis C virus | Q42980525 |
| | Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy. | Q42981378 |
| | Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection | Q42997373 |
| | Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C. | Q43031823 |
| | Multiparameter immune profiling of operational tolerance in liver transplantation | Q43035275 |
| | Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes | Q44523939 |
| | Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression | Q45219600 |
| | High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance | Q46732718 |
| | Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease. | Q51045089 |
| | Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells. | Q53340764 |
| | Cutting edge: critical role of inducible costimulator in germinal center reactions | Q56905311 |
| | Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors | Q56987977 |
| | Regulatory T cells in transplantation | Q61651648 |
| | Analyses of Peripheral Blood Mononuclear Cells in Operational Tolerance After Pediatric Living Donor Liver Transplantation | Q62735509 |
| P304 | page(s) | 1 | |
| P577 | publication date | 2016-01-20 | |
| P1433 | published in | Transplantation research | Q27724585 |
| P1476 | title | Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence | |
| P478 | volume | 5 | |